Filing Details

Accession Number:
0001683168-19-001919
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-17 16:20:12
Reporting Period:
2019-06-05
Accepted Time:
2019-06-17 16:20:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1622879 Medicine Man Technologies Inc. MDCL Services-Management Consulting Services (8742) 465289499
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654539 Justin Dye C/O Medicine Man Technologies, Inc.
4880 Havana Street, Suite 201
Denver CO 90239
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-05 1,500,000 $2.00 1,500,000 No 4 P Indirect See footnote 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote 1
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Acquisiton 2019-06-05 300,000 $0.00 300,000 $3.72
Common Stock Warrant to purchase common stock Acquisiton 2019-06-05 1,500,000 $0.00 1,500,000 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
300,000 2019-06-05 2022-06-05 No 4 A Direct
1,500,000 2019-06-05 2022-06-05 No 4 P Indirect
Footnotes
  1. On June 5, 2019, Medicine Man Technologies, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with Dye Capital Cann Holdings, LLC (the "Investor"). The Reporting Person has voting and investment control of the securities owned by the Investor and disclaims beneficial ownership of the securities for purposes of Section 16 except to the extent of the Reporting Person's pecuniary interest therein. Pursuant to the Purchase Agreement, the Investor purchased, in a private placement 1,500,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $2.00 per share and warrants (the "Warrants") to purchase 1,500,000 shares of Common Stock. The Warrants are for a term of three years and are exercisable at a price of $3.50.
  2. The Option vests in 1/2 increments on the one (1) and two (2) year anniversaries of the date of grant.